SOLVSolventum
Price
+17%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality mixed, nothing alarming, undemanding price, growing in the filings, the market undecided.
Solventum Corporation ("Solventum," "we," "our," "us," or the "Company"), is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Solventum (SOLV) reported revenue of $2.21B in Q2 2026 (quarter ended Jun 30, 2026), up 2.2% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $92M (4.2% of revenue). For the full year FY2025, revenue was $8.32B (+0.9% year on year) and net income $1.56B. Its largest segment in Q2 2026 was Med Surg at $537M, 42% of the disclosed total, ahead of Dental Solutions at 31%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 5, 2026Solventum Reports Second Quarter 2026 Financial Results.Earnings release · press release
- Aug 5, 2026The information furnished pursuant to this.Regulation FD disclosure · Form 8-K
- Jul 20, 2026On July 16, 2026, the Board of Directors of Solventum Corporation (the “Company”) appointed Neil Zieselman to serve as Senior Vice President, Controller and Chief Accounting Officer of the Company, effective as of August 10, 2026.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q2 2026 · $1.29BThe company’s own SEC segment disclosure.
- Med Surg$537.0M42%
- Dental Solutions$396.0M31%
- Health Information Systems$354.0M28%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
The closest names by size in the same industry